“We’re open for business,” said Taiho Oncology, Inc. CEO, Timothy Whitten. Alongside its growing pipeline of orally administered oncology drugs, the US subsidiary of Japan’s Taiho ...

Taiho. Gilead’s ex-U.S. control does not extend to Asia, where Taiho has held the rights (ex-China) since 2017. With the recent addition of quem, Taiho has opted into the same assets as Gilead ...

"These data add to the body of evidence for Taiho Oncology's expanding hematology portfolio and demonstrate our continued commitment to bring innovative therapies to patients with cancer." ...

Oho, making his debut in the highest makuuchi division, is a grandson of Taiho, the late yokozuna of the Showa Era (1926-1989), who dominated sumo in postwar Japan. Oho’s father is ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Rank-and-file wrestler Oho sprang the first big upset of the Kyushu Grand Sumo Tournament on Tuesday as he outmaneuvered ...

Arcus Biosciences Inc (RCUS) reports robust financial health and strategic advancements in late-stage trials, despite facing ...

Nguyen reported relationships with Black Diamond Therapeutics, Janssen Scientific Affairs, Taiho Oncology, Seagen/Pfizer, and ...